Company Profile
Ratio Therapeutics
Company Overview
Ratio Therapeutics is a clinical-stage biopharmaceutical company specializing in the emerging field of targeted radiotherapy of cancer and molecular imaging. Our focus is on the discovery, development, and commercialization of targeted therapeutic and imaging radiopharmaceuticals for use in oncology. We have an emergent pipeline of targeting candidates resulting from application of its proprietary TRILLIUM™ platform which allows fine tuning of pharmacokinetics and improvement in the therapeutic index. The company’s MACROPA™ chelator technology is uniquely matched for alpha therapy applications improving the manufacturing processes and enhancing in vivo behavior. Our mission is to provide best-in-class radiopharmaceuticals to cancer patients.